Estriol Completed Phase 2 Trials for Epistaxis / Hereditary Haemorrhagic Telangiectasia (HHT) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01408030North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)